Table 2.
Variable | Level | n | % | HBsAg positive | % of N | Relative risk (95% CI) | |
---|---|---|---|---|---|---|---|
Unadjusted | Adjusted* | ||||||
(a) British/Other | |||||||
Source | Secondary care | 53 957 | 68 | 271 | 0·50 | ||
Primary care | 25 768 | 32 | 226 | 0·88 | 1·75 (1·46–2·08) | 1·57 (1·31–1·88) | |
Gender | Female | 36 546 | 46 | 166 | 0·45 | ||
Male | 43 179 | 54 | 331 | 0·77 | 1·69 (1·4–2·03) | 1·69 (1·40–2·04) | |
Age group | 15–29 yr | 15 533 | 19 | 160 | 1·03 | ||
30–44 yr | 24 359 | 31 | 219 | 0·90 | 0·87 (0·71–1·07) | 0·83 (0·68–1·02) | |
>44 yr | 39 833 | 50 | 118 | 0·30 | 0·29 (0·23–0·36) | 0·30 (0·24–0·39) | |
NHS board | GG&C | 30 762 | 39 | 248 | 0·81 | ||
Other | 48 963 | 61 | 249 | 0·51 | 0·63 (0·53–0·75) | 0·66 (0·55–0·79) | |
(b) South Asian | |||||||
Referral | Secondary care | 1431 | 44 | 30 | 2·10 | ||
Source | Primary care | 1830 | 56 | 83 | 4·54 | 2·16 (1·43–3·28) | 2·05 (1·34–3·13) |
Gender | Female | 1159 | 36 | 25 | 2·16 | ||
Male | 2102 | 64 | 88 | 4·19 | 1·94 (1·24–3·03) | 1·81 (1·16–2·83) | |
Age group | 15–29 yr | 1127 | 35 | 33 | 2·93 | ||
30–44 yr | 1287 | 39 | 50 | 3·89 | 1·33 (0·85–2·06) | 1·25 (0·81–1·95) | |
>44 yr | 847 | 26 | 30 | 3·54 | 1·21 (0·74–1·98) | 1·25 (0·76–2·06) | |
NHS board | GG&C | 2056 | 63 | 75 | 3·65 | ||
Other | 1205 | 37 | 38 | 3·15 | 0·86 (0·59–1·28) | 0·95 (0·64–1·40) | |
(c) East Asian | |||||||
Referral | Secondary care | 503 | 45 | 101 | 20·08 | ||
Source | Primary care | 627 | 55 | 146 | 23·29 | 1·16 (0·90–1·49) | 1·22 (0·94–1·57) |
Gender | Female | 551 | 49 | 110 | 19·96 | ||
Male | 579 | 51 | 137 | 23·66 | 1·19 (0·92–1·52) | 1·13 (0·88–1·46) | |
Age group | 15–44 yr | 887 | 78 | 198 | 22·32 | ||
>44 yr | 243 | 22 | 49 | 20·16 | 0·90 (0·66–1·23) | 0·91 (0·66–1·24) | |
NHS board | GG&C | 489 | 43 | 134 | 27·40 | ||
Other | 641 | 57 | 113 | 17·63 | 0·64 (0·50–0·83) | 0·63 (0·49–0·82) |
CI, Confidence interval; GG&C, Greater Glasgow & Clyde.
Adjusted for source, gender, age and NHS board.